Provided by Tiger Trade Technology Pte. Ltd.

Warrior Met Coal LLC

108.24
+1.171.09%
Post-market: 108.240.00000.00%19:30 EDT
Volume:612.79K
Turnover:66.51M
Market Cap:5.69B
PE:26.02
High:110.50
Open:109.05
Low:107.91
Close:107.07
52wk High:111.20
52wk Low:54.66
Shares:52.57M
Float Shares:51.78M
Volume Ratio:1.07
T/O Rate:1.18%
Dividend:0.32
Dividend Rate:0.30%
EPS(TTM):4.16
EPS(LYR):1.08
ROE:10.04%
ROA:5.17%
PB:2.48
PE(LYR):100.22

Loading ...

Tokio Marine HCC International Acquires UK-Based Direct Commercial

MT Newswires Live
·
Yesterday

Press Release: Akeso 2026 Interim Results: Strong Commercialization Momentum; Io2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's

Dow Jones
·
Aug 28

IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed

Stock News
·
Aug 27

Warrior Met Coal CEO Walter J. Scheller Sells 50,000 Shares for $5.5 Million

Reuters
·
Aug 26

Warrior Met Coal Inc : Jefferies Raises Target Price to $125 from $110

THOMSON REUTERS
·
Aug 26

Press Release: Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

Dow Jones
·
Aug 25

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

GlobeNewswire
·
Aug 25

Press Release: Antengene Announces 2026 Interim Results: Achieves First

Dow Jones
·
Aug 24

Warrior Met Coal Director Stephen D. Williams Sells 4,800 Common Shares Worth $500,304

Reuters
·
Aug 22

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

GlobeNewswire
·
Aug 20

Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer

GlobeNewswire
·
Aug 17

Tvardi: Strategic Pivot to Ulcerative Colitis and Upcoming HCC Readouts Support Unchanged $9 Price Target and Buy Rating

TIPRANKS
·
Aug 15

Press Release: Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
Aug 13

Press Release: Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates

Dow Jones
·
Aug 12

RBC Capital Keeps Their Hold Rating on Warrior Met Coal (HCC)

TIPRANKS
·
Aug 12

Warrior Met Coal (HCC) Updates 2026 Guidance, Is It Still Below Fair Value?

Simply Wall St.
·
Aug 09

Alpha Metallurgical Q2 Adjusted Ebitda Misses Estimates on Lower Shipments

Reuters
·
Aug 07

Warrior Met Coal Price Target Cut to $98.00/Share from $100.00 by UBS

Dow Jones
·
Aug 07

UBS Adjusts Warrior Met Coal Price Target to $98 From $100, Maintains Buy Rating

MT Newswires Live
·
Aug 06

Analysts Offer Insights on Materials Companies: Linde (LIN), Warrior Met Coal (HCC) and Hudson Tech (HDSN)

TIPRANKS
·
Aug 06